This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Children's Medical Center Corporation, Fundacao Butantan, Path Vaccine Solutions. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2017
Title: Viviane Maimoni Gonçalves: Innovator in Immunogenic Compositions
Introduction
Viviane Maimoni Gonçalves is a prominent inventor based in São Paulo, Brazil. She has made significant contributions to the field of immunology, particularly through her innovative work on vaccine development. Her research focuses on creating effective immunogenic compositions that can enhance the immune response.
Latest Patents
Viviane holds a patent for a "Selectively disrupted whole-cell vaccine." This invention provides immunogenic compositions and methods for producing an immunogenic composition with multiple immunity-inducing fractions of killed whole cells. By selectively disrupting a whole cell bacterial preparation, her method ensures that both a soluble fraction, which induces a primarily antibody response, and a cellular fraction, which induces a primarily antibody-independent response, are retained in the immunogenic composition. This innovative approach has the potential to improve vaccine efficacy.
Career Highlights
Throughout her career, Viviane has worked with notable organizations, including Children's Medical Center Corporation and Path Vaccine Solutions. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in vaccine technology.
Collaborations
Viviane has collaborated with esteemed colleagues such as Richard Malley and Porter Anderson. These partnerships have further enriched her research and have led to advancements in the development of immunogenic compositions.
Conclusion
Viviane Maimoni Gonçalves is a trailblazer in the field of immunology, with her innovative patent and collaborative efforts paving the way for advancements in vaccine development. Her work continues to inspire future research in immunogenic compositions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile